Orban, Martin http://orcid.org/0000-0001-9830-1941
Kleeberger, Jan
Ouarrak, Taoufik
Freund, Anne
Feistritzer, Hans-Josef
Fuernau, Georg
Geisler, Tobias
Huber, Kurt
Dudek, Dariusz
Noc, Marko
Montalescot, Gilles
Neumer, Alexander
Haller, Paul
Clemmensen, Peter
Zeymer, Uwe
Desch, Steffen
Massberg, Steffen
Schneider, Steffen
Thiele, Holger
Hausleiter, Jörg
Funding for this research was provided by:
Deutsche Herzstiftung
FP7 Health
Institut für Herzinfarktforschung
Deutsche Forschungsgemeinschaft
Deutsche Gesellschaft für Kardiologie-Herz und Kreislaufforschung.
Deutsches Zentrum für Herz-Kreislaufforschung
Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte
Universität Leipzig
Maquet Cardiopulmonary AG
Teleflex Medical, Everett, MA, USA
Ludwig-Maximilians-Universität München
Article History
Received: 23 February 2021
Accepted: 30 April 2021
First Online: 17 May 2021
Declarations
:
: Martin Orban has received (directly or indirectly) speaker honoraria from Abbott Medical, AstraZeneca, Abiomed, Bayer vital, BIOTRONIK, Bristol-Myers Squibb, CytoSorbents, Daiichi Sankyo Deutschland, Edwards Lifesciences Services, Sedana Medical, outside the submitted work. Jörg Hausleiter received speaker honoraria and research support from Abbott Vascular and Edwards Lifesciences, outside the submitted work. Kurt Huber received lecture fees from AstraZeneca, Daiichi Sankyo and Sanofi Aventis, outside the submitted work. Peter Clemmensen has previously or currently been involved in research contracts, consulting, speakers bureau or received research and educational grants from: Abbott, Acarix, AstraZeneca, Aventis, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Daiichi Sankyo, Eli-Lilly, Evolva, Fibrex, Janssen, Merck, Myogen, Medtronic, Mitsubishi Pharma, The Medicines Company, Nycomed, Organon, Pfizer, Pharmacia, Regado, Sanofi, Searle, Servier, Quantum. Tobias Geisler reports speaker honoraria from Astra Zeneca, Boehringer Ingelheim, Ferrer, and Pfizer; grants and honoraria from BayerHealthcare, BristolMyers Squibb, Daiichi Sankyo, Medtronic and Edwards Lifesciences and is supported by the German Research Foundation (DFG) – Project number 374031971 – TRR 240. The other authors declare no conflict of interests.
: The study was performed according to the Declaration of Helsinki for Human Research and approved by the respective local ethics committees.
: Informed consent was obtained from all individual participants included in the study.
: All the authors consent to publication.